Chongdeng Shi

982 total citations
12 papers, 392 citations indexed

About

Chongdeng Shi is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Chongdeng Shi has authored 12 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Chongdeng Shi's work include Immune cells in cancer (5 papers), Immunotherapy and Immune Responses (4 papers) and CAR-T cell therapy research (3 papers). Chongdeng Shi is often cited by papers focused on Immune cells in cancer (5 papers), Immunotherapy and Immune Responses (4 papers) and CAR-T cell therapy research (3 papers). Chongdeng Shi collaborates with scholars based in China and Hong Kong. Chongdeng Shi's co-authors include Cai Zhang, Yuan Hu, Zhenmei Yang, Xinyi Jiang, Chunwei Tang, Maosen Han, Jing Zhang, Weiqiang Jing, Lin Gao and Chen Chen and has published in prestigious journals such as Advanced Materials, Chemical Engineering Journal and Journal of Controlled Release.

In The Last Decade

Chongdeng Shi

12 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chongdeng Shi China 11 191 161 125 91 36 12 392
Chunwei Tang China 10 137 0.7× 113 0.7× 106 0.8× 116 1.3× 49 1.4× 10 328
Zhenmei Yang China 12 141 0.7× 129 0.8× 126 1.0× 126 1.4× 62 1.7× 14 391
Iliana Tenvooren United States 7 248 1.3× 257 1.6× 165 1.3× 66 0.7× 28 0.8× 13 536
Junho Byun South Korea 11 169 0.9× 129 0.8× 208 1.7× 114 1.3× 47 1.3× 18 530
Aaron Dolor United States 7 117 0.6× 80 0.5× 114 0.9× 109 1.2× 53 1.5× 8 346
Runzi Sun United States 13 246 1.3× 177 1.1× 133 1.1× 77 0.8× 58 1.6× 17 452
Mathangi Srinivasan United States 6 155 0.8× 61 0.4× 129 1.0× 64 0.7× 49 1.4× 9 411
Chad A. Komar United States 3 200 1.0× 260 1.6× 155 1.2× 75 0.8× 16 0.4× 5 462
Jiakang Jin China 8 170 0.9× 97 0.6× 140 1.1× 72 0.8× 27 0.8× 10 375
Jinti Lin China 8 170 0.9× 97 0.6× 142 1.1× 72 0.8× 27 0.8× 10 375

Countries citing papers authored by Chongdeng Shi

Since Specialization
Citations

This map shows the geographic impact of Chongdeng Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chongdeng Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chongdeng Shi more than expected).

Fields of papers citing papers by Chongdeng Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chongdeng Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chongdeng Shi. The network helps show where Chongdeng Shi may publish in the future.

Co-authorship network of co-authors of Chongdeng Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Chongdeng Shi. A scholar is included among the top collaborators of Chongdeng Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chongdeng Shi. Chongdeng Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Zhao, Da‐Wang, Zhang Jing, Weiyi Sun, et al.. (2024). Rejuvenation Modulation of Nucleus Pulposus Progenitor Cells Reverses Senescence‐Associated Intervertebral Disc Degeneration. Advanced Materials. 37(7). e2409979–e2409979. 12 indexed citations
2.
Gao, Lin, Chongdeng Shi, Zhenmei Yang, et al.. (2023). Convection-enhanced delivery of nanoencapsulated gene locoregionally yielding ErbB2/Her2-specific CAR-macrophages for brainstem glioma immunotherapy. Journal of Nanobiotechnology. 21(1). 56–56. 47 indexed citations
3.
Jing, Weiqiang, Chen Chen, Ganyu Wang, et al.. (2023). Metabolic Modulation of Intracellular Ammonia via Intravesical Instillation of Nanoporter‐Encased Hydrogel Eradicates Bladder Carcinoma. Advanced Science. 10(12). e2206893–e2206893. 15 indexed citations
4.
Liu, Ying, Weiqiang Jing, Jing Zhang, et al.. (2023). In situ MUC1-specific CAR engineering of tumor-supportive macrophages stimulates tumoricidal immunity against pancreatic adenocarcinoma. Nano Today. 49. 101805–101805. 18 indexed citations
5.
Yang, Zhenmei, Ying Liu, Kun Zhao, et al.. (2023). Dual mRNA co-delivery for in situ generation of phagocytosis-enhanced CAR macrophages augments hepatocellular carcinoma immunotherapy. Journal of Controlled Release. 360. 718–733. 62 indexed citations
6.
Wang, Yanan, et al.. (2023). Liver-resident CD44hiCD27− γδT Cells Help to Protect Against Listeria monocytogenes Infection. Cellular and Molecular Gastroenterology and Hepatology. 16(6). 923–941. 2 indexed citations
7.
Chen, Chen, Chongdeng Shi, Xiaotian Zhao, et al.. (2023). Cell membrane derived liposomes loaded with DNase I target neutrophil extracellular traps which inhibits colorectal cancer liver metastases. Journal of Controlled Release. 357. 620–629. 49 indexed citations
8.
Zhao, Xiaotian, Jing Zhang, Chen Chen, et al.. (2023). Reversing immune evasion using a DNA nano-orchestrator for pancreatic cancer immunotherapy. Acta Biomaterialia. 166. 512–523. 12 indexed citations
9.
Shi, Chongdeng, Jing Zhang, Huijun Wang, et al.. (2022). Trojan Horse Nanocapsule Enabled In Situ Modulation of the Phenotypic Conversion of Th17 Cells to Treg Cells for the Treatment of Multiple Sclerosis in Mice. Advanced Materials. 35(11). e2210262–e2210262. 40 indexed citations
10.
Chen, Chen, Wei Du, Weiqiang Jing, et al.. (2021). Leveraging tumor cell ferroptosis for colorectal cancer treatment via nanoelicitor-activated tumoricidal immunity. Chemical Engineering Journal. 430. 132983–132983. 17 indexed citations
11.
Zhang, Cai, Yuan Hu, & Chongdeng Shi. (2020). Targeting Natural Killer Cells for Tumor Immunotherapy. Frontiers in Immunology. 11. 60–60. 92 indexed citations
12.
Chen, Chen, Shengchang Zhang, Rui Zhang, et al.. (2020). In situ tuning proangiogenic factor-mediated immunotolerance synergizes the tumoricidal immunity via a hypoxia-triggerable liposomal bio-nanoreactor. Theranostics. 10(26). 11998–12010. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chunwei Tang Breakdown of academic impact, for papers by Zhenmei Yang Breakdown of academic impact, for papers by Iliana Tenvooren Breakdown of academic impact, for papers by Junho Byun Breakdown of academic impact, for papers by Aaron Dolor Breakdown of academic impact, for papers by Runzi Sun Breakdown of academic impact, for papers by Mathangi Srinivasan Breakdown of academic impact, for papers by Chad A. Komar Breakdown of academic impact, for papers by Jiakang Jin Breakdown of academic impact, for papers by Jinti Lin
Rankless by CCL
2026